Crossing barriers: the burden of inflammatory bowel disease across Western Europe
An estimated 2.5–3 million individuals (0.4%) in Europe are affected by inflammatory bowel disease (IBD). Whilst incidence rates for IBD are stabilising across Europe, the prevalence is rising and subsequently resulting in a significant cost to the healthcare system of an estimated 4.6–5.6 billion e...
Glavni autori: | , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Članak |
Jezik: | English |
Izdano: |
SAGE Publishing
2023-12-01
|
Serija: | Therapeutic Advances in Gastroenterology |
Online pristup: | https://doi.org/10.1177/17562848231218615 |